Results 91 to 100 of about 14,072 (183)

Mixed Lineage Kinase Domain‐Like Protein (MLKL): From Mechanisms to Therapeutic Opportunities

open access: yesAdvanced Science
Lytic forms of regulated cell death (RCD) rely on the activation and recruitment of executioner proteins. The mixed lineage kinase domain‐like protein (MLKL) acts as the executioner in the necroptosis pathway, transitioning from an inactive to active ...
Lijuan Xu, Chunlin Zhuang
doaj   +1 more source

NET formation can occur independently of RIPK3 and MLKL signaling [PDF]

open access: yes, 2016
The importance of neutrophil extracellular traps (NETs) in innate immunity is well established but the molecular mechanisms responsible for their formation are still a matter of scientific dispute.
Kaufmann, Thomas   +23 more
core   +2 more sources

Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis [PDF]

open access: yes, 2018
Necroptotic cell death is mediated by the most terminal known effector of the pathway, MLKL. Precisely how phosphorylation of the MLKL pseudokinase domain activation loop by the upstream kinase, RIPK3, induces unmasking of the N-terminal executioner four-
Wardak, A   +75 more
core   +1 more source

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

open access: yesJournal of Visualized Experiments, 2018
Necroptosis is a programmed cell death pathway triggered by activation of receptor interacting protein kinase 3 (RIPK3), which phosphorylates and activates the mixed lineage kinase-like domain pseudokinase, MLKL, to rupture or permeabilize the plasma membrane.
Dan E, McNamara   +4 more
openaire   +3 more sources

The Evolution and Biological Activity of Metazoan Mixed Lineage Kinase Domain-Like Protein (MLKL)

open access: yes
In mammals, mixed lineage kinase domain-like protein (MLKL) is the executor of necroptosis. MLKL comprises an N-terminal domain (NTD), which alone suffices to trigger necroptosis by forming pores in the plasma membrane, and a C-terminal domain that ...
Zihao Yuan   +4 more
core   +1 more source

MLKL Modulates Necroptosis and Neuroinflammation in a Mouse Model of MS

open access: yesInflammation
MLKL not only plays an important role in necroptosis but also regulates many diseases through non-necrotizing apoptotic function. Many studies have shown that MLKL plays an important role in neuroinflammation, degenerative diseases, and infectious diseases.
Xiao, Minjun   +5 more
openaire   +3 more sources

Chemical structure of MLKL binders described in text.

open access: yes, 2016
Chemical structure of MLKL binders described in text.
Doug Marcotte (2221630)   +12 more
core   +1 more source

Saracatinib inhibits necroptosis and ameliorates psoriatic inflammation by targeting MLKL

open access: yes
Necroptosis is a kind of programmed cell death that causes the release of damage-associated molecular patterns and inflammatory disease including skin inflammation.
Xuan Chen   +13 more
core   +1 more source

Označevanje aktivne oblike MLKL

open access: yes, 2020
Nekroptoza je ena izmed oblik programirane nekroze, pri kateri ima ključno vlogo protein MLKL (ang. mixed lineage kinase-domain like), ki ob aktivaciji oligomerizira, se vgradi v plazmalemo in povzroči sprostitev celične vsebine. V signalni poti imajo pomembno vlogo tudi drugi nekroptotični proteini, predvsem kinazi RIPK1 in RIPK3. Nekroptoza nastopi v
openaire   +1 more source

Acylation of MLKL Impacts Its Function in Necroptosis

open access: yes
Mixed lineage kinase domain-like (MLKL) is a key signaling protein of necroptosis. Upon activation by phosphorylation, MLKL translocates to the plasma membrane and induces membrane permeabilization, which contributes to the necroptosis-associated ...
G. Ekin Atilla-Gokcumen (1646659)   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy